Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

Skin debridement and antifungals successfully treated severe scalp infection without scarring.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Ketoconazole improved symptoms of ACTH-independent Cushing syndrome despite inconclusive initial scans.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

The monkeys' skin infection was cured in eight weeks using oral terbinafine, topical washes, and disinfectant fogging.

Elagolix did not effectively treat polycystic ovary syndrome.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.